Get started
Author

О. А. Markova

Observed names: O. A. Markova, O.A. Markova, Oksana A. Markova, Oksana Anatolievna Markova, Oksana Markova, Маркова Оксана Анатольевна
Observed institution: Generium Pharmaceuticals (Russia)
ORCID: 0000-0002-1179-3881
Observed ORCID: 0000-0002-1179-3881
OpenAlex ID: A5035417997
Comparison of biosimilar Tigerase and Pulmozyme in long-term symptomatic therapy of patients with cystic fibrosis and severe pulmonary impairment (subgroup analysis of a Phase III randomized open-label clinical trial (NCT04468100))
2021 · Elena L. Amelina, Stanislav A. Krasovsky, et al. · PLoS ONE · 36
Results of phase Ib open multicenter clinical trial of the safety, pharmacokinetics and pharmacodynamics of first biosimilar of eculizumab in untreated patients with paroxysmal nocturnal hemoglobinuria during induction of therapy
2020 · V. V. Ptushkin, A. D. Kulagin, et al. · Terapevticheskii arkhiv · 36
PDF
Randomized multicenter noninferiority phase III clinical trial of the first biosimilar of eculizumab
2021 · Alexander D. Kulagin, Vadim V. Ptushkin, et al. · Annals of Hematology · 33
PDF
Phase III Clinical Trial of Elizaria® and Soliris® in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria: Results of Comparative Analysis of Efficacy, Safety, and Pharmacological Data
2019 · Aleksandr Kulagin, Vadim Ptushkin, et al. · Blood · 29
Results of Long-Term Therapy with a Biosimilar of Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria
2024 · Alexander D. Kulagin, Vadim V. Ptushkin, et al. · Acta Haematologica · 6
PDF
Results of a phase I open randomized comparative crossover clinical trial to assess the safety and pharmacokinetics of Glurazyme® (imiglucerase) in comparison with the reference product in healthy volunteers
2019 · S. B. Fitilev, A. V. Vozzhaev, et al. · Oncohematology · 6
Evaluation of the efficacy and safety of the biosimilar drug Glurazyme (imiglucerase) in patients with Gaucher disease type 1
2020 · E. P. Sysoeva, R. V. Ponomarev, et al. · Гематология и трансфузиология · 5
PDF
Dornase alfa in the treatment of COVID-19: destruction of neutrophil extracellular traps
2020 · E. L. Amelina, N. Yu. Kashirskaya, et al. · PULMONOLOGIYA · 4
PDF
Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III
2024 · E. V. Akatova, Yu. S. Bakhareva, et al. · Modern Rheumatology Journal · 3
PDF
Experience in the production and clinical application of the cell-based medicinal product Easytense® for the repair of cartilage defects of the human knee
2024 · A. S. Zoricheva, E. A. Zvonova, et al. · Biological Products Prevention Diagnosis Treatment · 3
Virus neutralizing antibodies in pseudovirus particle neutralization reaction as a bioanalytical part of a Salnavac® vaccine clinical trial
2023 · Evgeniy V. Zuev, Oksana Anatolievna Markova, et al. · Russian Journal of Infection and Immunity · 3
Specificity of the Moroctocog Alpha Molecule: Results of a Prospective, Multicenter, Open-label, Observational Study of Efficacy and Safety in Children Aged 12 to 18 Years With Hemophilia a
2021 · V.V. Vdovin, M.V. Kosinova, et al. · PEDIATRIA Journal named after G N SPERANSKY · 3
Pre‐Seasonal Treatment With Recombinant Carrier‐Based Birch Vaccine Improves Birch Pollen Allergy
2026 · Musa R. Khaitov, Maria G. Byazrova, et al. · Allergy · 2
PDF
Safety, tolerability, and pharmacokinetics of verenafusp alfa in healthy volunteers: results of an open-label multicohort phase I study
2026 · Elena A. Smolyarchuk, Susanna S. Sologova, et al. · Terapevticheskii arkhiv · 2
PDF
T-cell sensitization dynamics after intranasal and intramuscular immunization with a two-component vector vaccine for the prevention of coronavirus infection based on Ad26 and Ad5
2024 · E.V. Zuev, O.A. Markova, et al. · Immunologiya · 2
PDF
Comparative safety evaluation of intranasal and intramuscular immunisation with Ad26 and Ad5-vectored vaccines to prevent coronavirus infection
2023 · E. V. Zuev, O. L. Evdokimova, et al. · Biological Products Prevention Diagnosis Treatment · 2
PDF
Results of Open, Prospective, Multicenter, Non-comparative Study of Nonacog Alpha Pharmacokinetics, Efficacy and Safety in Children Aged 2–12 Years With Severe and Moderate Hemophilia В
2022 · T.A. Andreeva, V.V. Lebedev, et al. · PEDIATRIA Journal named after G N SPERANSKY · 2
Interim results of a multicenter, open-label, multicohort study of enzyme replacement therapy with Verenafusp Alfa in patients under 18 years of age with Mucopolysaccharidosis Type II
2026 · L.S. Namazova-Baranova, N.D. Vashakmadze, et al. · PEDIATRIA Journal named after G N SPERANSKY · 1
Results of a prospective observational study of imiglucerase biosimilar in adults with type I Gaucher disease
2025 · Elena A. Lukina, Rodion V. Ponomarev, et al. · Terapevticheskii arkhiv · 1
Efficacy and Safety of Moroctocog Alfa in an Open, Multicenter, Prospective, Clinical Study in Children 2 to 6 Years of Age With Severe Hemophilia a
2021 · M.A. Timofeeva, V.V. Lebedev, et al. · PEDIATRIA Journal named after G N SPERANSKY · 1
Results of the Open Multicenter Prospective Clinical Study of the Efficacy, Safety, and Pharmacokinetics of Moroctocog Alpha in 6 to 12 Year Old Children With Hemophilia a
2021 · M.A. Timofeeva, T.A. Andreeva, et al. · PEDIATRIA Journal named after G N SPERANSKY · 1
Results of a Prospective Multicenter Open-label Observational Study of Enzyme Replacement Therapy With an Imiglucerase Biosimilar in Children With Type 1 Gaucher Disease
2026 · G.B. Movsisyan, A.S. Potapov, et al. · PEDIATRIA Journal named after G N SPERANSKY
Long-term therapy with eculizumab biosimilar in patients with paroxysmal nocturnal hemoglobinuria: Two-year interim results of a prospective multicenter observational study
2025 · Alexander Kulagin, Elena Lukina, et al. · Blood
PDF
Results of an Open, Prospective, Multicenter, Noncomparative Study of the Pharmacokinetics, Efficacy and Safety of Nonacog Alfa in Patients Aged 6–12 Years With Severe and Moderate Hemophilia B
2020 · T.A. Andreeva, V.V. Lebedev, et al. · PEDIATRIA Journal named after G N SPERANSKY
Результаты проспективного наблюдательного исследования биоаналога имиглюцеразы у взрослых пациентов с болезнью Гоше I типа
· Пономарев Родион Викторович, Лукина Елена Александровна, et al. · CyberLeninK (CyberLeninka)
Works count: 26
Citation count: 181
H-index: 6
I10-index: 4
Year
Topic
Type